Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

291 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Active immunization of patients with HIV infection: a study of the effect of VaxSyn, a recombinant HIV envelope subunit vaccine, on progression of immunodeficiency.
Tsoukas CM, Raboud J, Bernard NF, Montaner JS, Gill MJ, Rachlis A, Fong IW, Schlech W, Djurdjev O, Freedman J, Thomas R, Lafrenière R, Wainberg MA, Cassol S, O'Shaughnessy M, Todd J, Volvovitz F, Smith GE. Tsoukas CM, et al. AIDS Res Hum Retroviruses. 1998 Apr 10;14(6):483-90. doi: 10.1089/aid.1998.14.483. AIDS Res Hum Retroviruses. 1998. PMID: 9566550 Clinical Trial.
New CD4(+) cell line susceptible to infection by HIV-1.
Tremblay M, Sullivan AK, Rooke R, Geleziunas R, Tsoukas C, Shematek G, Gilmore N, Wainberg MA. Tremblay M, et al. Among authors: tsoukas c. J Med Virol. 1989 Aug;28(4):243-9. doi: 10.1002/jmv.1890280408. J Med Virol. 1989. PMID: 2570823
Clinical correlates and molecular basis of HIV drug resistance.
Wainberg MA, Gu Z, Gao Q, Arts E, Geleziunas R, Bour S, Beaulieu R, Tsoukas C, Singer J, Montaner J. Wainberg MA, et al. Among authors: tsoukas c. J Acquir Immune Defic Syndr (1988). 1993;6 Suppl 1:S36-46. J Acquir Immune Defic Syndr (1988). 1993. PMID: 7678865 Review.
Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.
Salomon H, Wainberg MA, Brenner B, Quan Y, Rouleau D, Coté P, LeBlanc R, Lefebvre E, Spira B, Tsoukas C, Sekaly RP, Conway B, Mayers D, Routy JP. Salomon H, et al. Among authors: tsoukas c. AIDS. 2000 Jan 28;14(2):F17-23. doi: 10.1097/00002030-200001280-00003. AIDS. 2000. PMID: 10708278
Clinical significance and characterization of AZT-resistant strains of HIV-1.
Wainberg MA, Rooke R, Tremblay M, Li X, Parniak MA, Gao Q, Yao XJ, Tsoukas C, Montaner J, Fanning M, Ruedy J. Wainberg MA, et al. Among authors: tsoukas c. Can J Infect Dis. 1991 Spring;2(1):5-11. doi: 10.1155/1991/124860. Can J Infect Dis. 1991. PMID: 22451746 Free PMC article.
Didanosine compared with continued zidovudine therapy for HIV-infected patients with 200 to 500 CD4 cells/mm3. A double-blind, randomized, controlled trial. Canadian HIV Trials Network Protocol 002 Study Group.
Montaner JS, Schechter MT, Rachlis A, Gill J, Beaulieu R, Tsoukas C, Raboud J, Cameron B, Salomon H, Dunkle L, Smaldone L, Wainberg MA. Montaner JS, et al. Among authors: tsoukas c. Ann Intern Med. 1995 Oct 15;123(8):561-71. doi: 10.7326/0003-4819-123-8-199510150-00001. Ann Intern Med. 1995. PMID: 7677296 Clinical Trial.
291 results